参考文献/References:
[1]Jain R, Scarpace LM, Ellika S,et al.Imaging response criteria for recurrent gliomas treated with bevacizumab:role of diffusion weighted imaging as an imaging biomarker[J].J Neurooncol,2010,96(3):423
[2]徐俊玲,李永丽,连建敏,等.二维氢质子磁共振波谱分析鉴别胶质瘤术后复发和放射性脑损伤[J].中国医学影像技术,2010,26(4):639
[3]Xu JL, Shi DP, Dou SW,et al. Distinction between postoperative recurrent glioma and delayed radiation injury using MR perfusion weighted imaging[J]. J Med Imaging Radiat Oncol, 2011, 55(6):587
[4]Hein PA, Eskey CJ, Dunn JF, et al. Diffusion weighted imaging in the followup of treated highgrad gliomas: tumor recurrence versus radiation injury[J]. Am J Neuroradiol, 2004,25(1):201
[5]Zhou XJ, Leeds NE, Kumar AJ, et al. Differentiation of tumor recurrence from treatmentinduced necrosis using quantitative diffusion MRI[J].Proc Intl Soc Mag Reson Med, 2010,9(3):726
[6]Tung GA, Evangelista P, Rogg JM, et al. Diffusionweighted MR imaging of rimenhancing brain masses: is markedly decreased water diffusion specific for brain abcess?[J]. AJR, 2001,177(3):709
[7]Biousse V, Newman NJ, Hunter SB, et al. Diffusion weighted imaging in radiation necrosis[J]. J Neurol Neurosurg Psychiatry, 2003,74(3):382
[8]Sundgren PC, Fan XY, Weybright P, et al. Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrastenhancing lesions[J]. Magn Reson Imaging, 2006,24(9):1131
[9]Beppu T, Inoue T, Shibata Y, et al. Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors[J]. J Neurooncol, 2003,63(2):109
[10]Sinha S, Bastin ME, Whittle IR, et al. Diffusion tensor MR imaging of highgrade cerebral gliomas[J]. Am J Neuroradiol, 2002,23(4):520
[11]Kashimura H, Inoue T, Beppu T, et al. Diffusion tensor imaging for differentiation of recurrent brain tumor and radiation necrosis after radiotherapythree case reports[J]. Clin Neurol Neurosurg, 2007,109(1):106